Literature DB >> 15316680

Chondroblastoma of the hands and feet.

Jesse A Davila1, Kimberly K Amrami, Murali Sundaram, Mark C Adkins, Krishnan K Unni.   

Abstract

OBJECTIVE: To review the imaging findings, age and gender distribution of chondroblastoma of the hands and feet. DESIGN AND PATIENTS: Twenty-five cases of pathologically proven chondroblastoma of the hands and feet were reviewed. Available imaging modalities included radiographs (n=24), CT (n=3), MRI (n=5), and radionuclide bone scintigraphy (n=1). The following imaging features for each case were tabulated: location, presence of sclerotic margin, calcification, expansion, presence of fluid/fluid levels on cross-sectional imaging and surrounding edema on MRI. The images were evaluated for skeletal maturity using closure of the physeal plate in the region as a standard.
RESULTS: The average age at time of diagnosis was 23 years (range 7-57 years). Eighty-four percent (n=21) of the patients were skeletally mature. Males (20 of 25) outnumbered females by a ratio of 5:1. The bones of the foot accounted for 22 cases: calcaneus (n=8), talus (n=8), metatarsals (n=3), and the cuboid (n=3). The bones of the hand accounted for three cases: phalanx (n=1), triquetrum (n=1), and a metacarpal (n=1). Radiographically all lesions were osteolytic with identifiable calcification in 54% (13 of 24). Fluid/fluid levels were seen in four of five cases on MRI. Edema on MR images was seen in 40% (2 of 5). The size of the lesions ranged from 2 to 41 cm(2).
CONCLUSION: Chondroblastomas of the hands and feet share many of the radiographic characteristics seen in the long bones, but manifest in skeletally mature patients with a higher male to female ratio than in long bone chondroblastoma. Talar and calcaneal lesions were encountered only in males. Chondroblastoma of the wrist and hand appears to be exceptionally rare.

Entities:  

Mesh:

Year:  2004        PMID: 15316680     DOI: 10.1007/s00256-004-0762-1

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  24 in total

1.  Benign chondroblastoma.

Authors:  M G KUNKEL; D C DAHLIN; H H YOUNG
Journal:  J Bone Joint Surg Am       Date:  1956-07       Impact factor: 5.284

2.  The roentgenographic features of chondroblastoma.

Authors:  R A McLeod; J W Beabout
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1973-06

3.  Tumors of the bones of the feet: the clinicopathologic features of 150 cases.

Authors:  B Bakotic; A G Huvos
Journal:  J Foot Ankle Surg       Date:  2001 Sep-Oct       Impact factor: 1.286

4.  Benign chondroblastoma of talus demonstrated by skeletal scanning.

Authors:  S Ulreich; G Swartz; S A Stier; E Philips
Journal:  Clin Nucl Med       Date:  1978-02       Impact factor: 7.794

5.  Chondroblastoma of the talus: natural development over 9.5 years. Case report.

Authors:  P E Ochsner; A R von Hochstetter; B Hilfiker
Journal:  Arch Orthop Trauma Surg       Date:  1988

6.  An unusual case of cystic chondroblastoma of the calcaneus: a case report.

Authors:  C Barbera; N Pinotti; M J Klein; M M Lewis
Journal:  Bull Hosp Jt Dis Orthop Inst       Date:  1988

Review 7.  Chondroblastoma of the foot.

Authors:  B R Fink; H T Temple; F M Chiricosta; M S Mizel; M D Murphey
Journal:  Foot Ankle Int       Date:  1997-04       Impact factor: 2.827

8.  Chondroblastoma of the talus.

Authors:  G V Yu; C S Sellers
Journal:  J Foot Ankle Surg       Date:  1996 Jan-Feb       Impact factor: 1.286

9.  Chondroblastoma.

Authors:  R E Turcotte; A M Kurt; F H Sim; K K Unni; R A McLeod
Journal:  Hum Pathol       Date:  1993-09       Impact factor: 3.466

10.  Chondroblastoma. A review of seventy cases.

Authors:  D S Springfield; R Capanna; F Gherlinzoni; P Picci; M Campanacci
Journal:  J Bone Joint Surg Am       Date:  1985-06       Impact factor: 5.284

View more
  15 in total

1.  Chondroblastoma in adult age.

Authors:  Andrea Angelini; Mohammad Hassani; Andreas F Mavrogenis; Giulia Trovarelli; Carlo Romagnoli; Antonio Berizzi; Pietro Ruggieri
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-20

Review 2.  Capitate Chondroblastoma: A Case Report and Review of the Literature.

Authors:  Ali Izadpanah; Riyam T Zreik; Thomas Shives; Sanjeev Kakar
Journal:  Hand (N Y)       Date:  2016-07-08

Review 3.  The imaging of cartilaginous bone tumours. I. Benign lesions.

Authors:  H Douis; A Saifuddin
Journal:  Skeletal Radiol       Date:  2012-06-17       Impact factor: 2.199

4.  An uncommon presentation of giant cell tumor.

Authors:  Hunaina Al-Kindi; Mina George; Gopal Malhotra; Khamis Al-Muzahmi
Journal:  Oman Med J       Date:  2011-09

Review 5.  Tumors of the hand.

Authors:  Andreas F Mavrogenis; Georgios N Panagopoulos; Andrea Angelini; Jan Lesenský; Christos Vottis; Panayiotis D Megaloikonomos; Zinon T Kokkalis; Vasilios Kontogeorgakos; Pietro Ruggieri; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-05

Review 6.  [Tumors of the foot skeleton].

Authors:  K Ludwig
Journal:  Radiologe       Date:  2007-03       Impact factor: 0.635

7.  Prevalence, extension and characteristics of fluid-fluid levels in bone and soft tissue tumors.

Authors:  P Van Dyck; F M Vanhoenacker; J Vogel; C Venstermans; H M Kroon; J Gielen; P M Parizel; J L Bloem; A M A De Schepper
Journal:  Eur Radiol       Date:  2006-04-13       Impact factor: 5.315

8.  Primary osseous tumors of the hindfoot: why the delay in diagnosis and should we be concerned?

Authors:  Peter S Young; Stuart W Bell; Elaine M MacDuff; Ashish Mahendra
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

9.  Fluid-fluid levels in bone neoplasms: variation of T1-weighted signal intensity of the superior to inferior layers--diagnostic significance on magnetic resonance imaging.

Authors:  Faisal Alyas; Asif Saifuddin
Journal:  Eur Radiol       Date:  2008-06-11       Impact factor: 5.315

10.  Chondroblastoma of the navicular bone.

Authors:  Xiao Na Li; Zhi Gang Peng; Jing Pin Zhao; Ze Kun Zhang
Journal:  Iran J Radiol       Date:  2014-10-20       Impact factor: 0.212

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.